Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT05060471What this trial is testingPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsWho this might be right forAnal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more Sun Yat-sen University 25
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Not applicableStudy completedNCT00059891What this trial is testingAnal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal CancerWho this might be right forAnal CancerColorectal CancerPerioperative/Postoperative Complications Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00025090What this trial is testingRadiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerWho this might be right forAnal Cancer University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04719988What this trial is testingAnti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.Who this might be right forSquamous Cell Carcinoma of the Anus Stage III Centre Hospitalier Universitaire de Besancon 55
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Large-scale testing (Phase 3)Study completedNCT00003652What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer UNICANCER 350
Large-scale testing (Phase 3)UnknownNCT05374252What this trial is testingChemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsWho this might be right forAnal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more Sixth Affiliated Hospital, Sun Yat-sen University 102
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableStudy completedNCT01836926What this trial is testingTaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.Who this might be right forRectal Cancer Osama Mohammad Ali ElDamshety 110
Testing effectiveness (Phase 2)Study completedNCT00316888What this trial is testingCetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerWho this might be right forAnal Cancer ECOG-ACRIN Cancer Research Group 63
Large-scale testing (Phase 3)Looking for participantsNCT07692152What this trial is testingSintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell CarcinomaWho this might be right forAnal Squamous Cell Carcinoma, Limited-stage Cancer Institute and Hospital, Chinese Academy of Medical Sciences 350
Large-scale testing (Phase 3)Active Not RecruitingNCT06866574What this trial is testingA Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesWho this might be right forPenile/Perineal /Perianal Intraepithelial NeoplasiaAnal Intraepithelial NeoplasiaPenile/Perianal/Perineal Cancer+2 more Xiamen University 9,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028What this trial is testingTherapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerWho this might be right forAIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00003596What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer Radiation Therapy Oncology Group 682
Large-scale testing (Phase 3)UnknownNCT05668572What this trial is testingA Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV VaccineWho this might be right forHuman Papillomavirus Infection Beijing Health Guard Biotechnology, Inc 12,000